Madhuraj Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.35 M
- Company Age 25 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.38 M
About Madhuraj Diagnostics
Madhuraj Diagnostics Private Limited (MDPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 May 1999 and has a history of 25 years and nine months. Its registered office is in Kanpur Nagar, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.35 M.
The company currently has active open charges totaling ₹2.38 M.
Meenakshi Singhal, Raj Loomba, and Neelam Agarwal serve as directors at the Company.
Company Details
-
Location
Kanpur Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85110UP1999PTC024430
-
Company No.
024430
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 May 1999
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Madhuraj Diagnostics?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Loomba
|
Managing Director | 14-May-1999 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Meenakshi Singhal
|
Whole-Time Director | 14-May-1999 | Current |
|
Neelam Agarwal
|
Whole-Time Director | 14-May-1999 | Current |
Financial Performance of Madhuraj Diagnostics.
Madhuraj Diagnostics Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Madhuraj Diagnostics?
In 2017, Madhuraj Diagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Madhuraj Hospital Private LimitedRaj Loomba is a mutual person
-
Vetos Pharmaceuticals Private LimitedNeelam Agarwal is a mutual person
Charges (Loans)
₹2.38 M
₹0
Charges Breakdown by Lending Institutions
- Ge Capital Services India : 0.24 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Jun 2007 | Ge Capital Services India | ₹2.38 M | Open |
How Many Employees Work at Madhuraj Diagnostics?
Unlock and access historical data on people associated with Madhuraj Diagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Madhuraj Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Madhuraj Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
